首页|超声引导下微波消融和射频消融对甲状腺良性结节患者甲状腺功能及安全性的影响对比

超声引导下微波消融和射频消融对甲状腺良性结节患者甲状腺功能及安全性的影响对比

扫码查看
目的:比较超声引导下微波消融(MWA)和射频消融(RFA)对甲状腺良性结节患者甲状腺功能及安全性的影响.方法:回顾性选取2020年1月—2023年1月于新疆医科大学第七附属医院治疗的甲状腺良性结节患者92例,根据手术方式不同分为MWA组和RFA组,各46例,MWA组采用超声引导下微波消融治疗,RFA组采用超声引导下射频消融治疗.观察两组消融时间、单位体积消融时间、甲状腺功能[促甲状腺激素(TSH)、血清游离甲状腺三碘原氨酸(FT3)、游离甲状腺素(FT4)]、炎症因子[白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和C反应蛋白(CRP)]水平.结果:(1)MWA组的消融时间、单位体积消融时间均短于RFA组(P<0.05);(2)治疗前,两组结节体积差异无统计学意义(P>0.05),治疗后 3 个月结节体积均较治疗前降低(P<0.05),且MWA组结节体积小于RFA组(P<0.05),MWA组结节缩小率高于RFA组(P<0.05);(3)治疗前,两组TSH、FT3、FT4 差异均无统计学意义(P>0.05),治疗后 7 d两组TSH较治疗前均有所升高(P<0.05),FT4 均有所降低(P<0.05),且MWA组TSH低于RFA组(P<0.05),FT3、FT4 均高于RFA组(P<0.05);(4)治疗前,两组炎症因子(IL-6、TNF-α和CRP)差异均无统计学意义(P>0.05),治疗后 7 d两组炎症因子较治疗前均有所升高(P<0.05),但MWA组各炎症因子指标均低于RFA组(P<0.05);(5)MWA组的并发症发生率为 15.22%,高于RFA组的 2.17%(P<0.05).结论:MWA可有效减少甲状腺良性结节的消融时间和单位体积消融时间,对甲状腺功能及炎症因子水平影响较小,但安全性较RFA略差.
Comparison of the Effects of Ultrasound-guided Microwave Ablation and Radiofrequency Ablation on Thyroid Function and Safety in Patients with Benign Thyroid Nodules
Objective:To compare the effects of ultrasound-guided microwave ablation(MWA)and radiofrequency ablation(RFA)on thyroid function and safety in patients with benign thyroid nodules.Method:Ninety-two patients with benign thyroid nodules treated at the Seventh Affiliated Hospital of Xinjiang Medical University from January 2020 to January 2023 were selected retrospectively and divided into the MWA group and RFA group according to the different surgical methods,each with 46 cases;the MWA group was treated with ultrasound-guided microwave ablation,and the RFA group was treated with ultrasound-guided radiofrequency ablation.The ablation time,ablation time per unit volume,thyroid function[thyroid-stimulating hormone(TSH),serum free thyroid triiodothyronine(FT3),free thyroxine(FT4)],and inflammatory factors[interleukin-6(IL-6),tumor necrosis factor-alpha(TNF-α),and C reactive protein(CRP)]of the two groups were observed.Result:(1)The ablation time and ablation time per unit volume of the MWA group were shorter than those of the RFA group(P<0.05);(2)before treatment,there was no significant difference in the volume of nodules between the two groups(P>0.05),and the nodule volume was reduced 3 months after treatment compared with the pre-treatment period(P<0.05),and the nodule volume of the MWA group was smaller than that of the RFA group(P<0.05),and the nodule shrinkage rate of the MWA group was higher than that of the RFA group(P<0.05);(3)before treatment,there were no significant differences in TSH,FT3 and FT4 between the two groups(P>0.05),and TSH were increased and FT4 were decreased 7 d after treatment compared with the pre-treatment(P<0.05),and TSH in the MWA group was lower than that of the RFA group(P<0.05),and FT3 and FT4 in the MWA group were higher than those of the RFA group(P<0.05);(4)before treatment,there were no significant differences in the inflammatory factors(IL-6,TNF-α and CRP)between the two groups(P>0.05),and the inflammatory factors were increased 7 d after treatment compared with those before treatment(P<0.05),but the indexes of each inflammatory factor in the MWA group were lower than those in the RFA group(P<0.05);(5)the complications in the MWA group was 15.22%,which was higher than 2.17%in the RFA group(P<0.05).Conclusion:MWA is effective in reducing the ablation time and ablation time per unit volume of benign thyroid nodules,and has less impact on thyroid function and inflammatory factor levels,but has a slightly worse safety profile than RFA.

Ultrasound guidanceMicrowave ablationRadiofrequency ablationBenign thyroid nodulesThyroid functionSafety

单尧飞、玛依努尔·买买提明、胡佳俊

展开 >

新疆医科大学第七附属医院超声诊断科 新疆 乌鲁木齐 830028

超声引导 微波消融 射频消融 甲状腺良性结节 甲状腺功能 安全性

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(8)
  • 21